1. Home
  2. TRGS vs CATX Comparison

TRGS vs CATX Comparison

Compare TRGS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRGS

TRG Latin America Acquisitions Corp. Class A Ordinary Shares

N/A

Current Price

$9.99

Market Cap

259.4M

Sector

Finance

ML Signal

N/A

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

N/A

Current Price

$0.79

Market Cap

97.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRGS
CATX
Founded
2025
1983
Country
United States
United States
Employees
N/A
166
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.4M
97.7M
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
TRGS
CATX
Price
$9.99
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
★ $9.93
AVG Volume (30 Days)
50.7K
★ 3.7M
Earning Date
N/A
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$46.31
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.88
$0.78
52 Week High
$10.03
$6.16

Technical Indicators

Market Signals
Indicator
TRGS
CATX
Relative Strength Index (RSI) 59.61 19.61
Support Level N/A N/A
Resistance Level $10.03 $2.40
Average True Range (ATR) 0.00 0.21
MACD -0.00 -0.03
Stochastic Oscillator 100.00 0.40

Price Performance

Historical Comparison
TRGS
CATX

About TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares

TRG Latin America Acquisitions Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: